iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Trading Down 0.2% – Here’s Why

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) traded down 0.2% on Tuesday . The company traded as low as $24.79 and last traded at $24.91. 1,818 shares were traded during trading, an increase of 106% from the average session volume of 884 shares. The stock had previously closed at $24.97.

iShares Neuroscience and Healthcare ETF Stock Performance

The stock has a market capitalization of $3.74 million, a PE ratio of 28.31 and a beta of 1.06. The business has a 50 day moving average of $25.70 and a two-hundred day moving average of $25.94.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in iShares Neuroscience and Healthcare ETF stock. Jane Street Group LLC purchased a new stake in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 10,150 shares of the company’s stock, valued at approximately $254,000. Jane Street Group LLC owned 6.77% of iShares Neuroscience and Healthcare ETF at the end of the most recent quarter.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.